What Can We Learn from Marine Invertebrates to be Used as Complementary Antibiotics?
Several biotechnology start-ups are engaged in developing novel antibiotics using antimicrobial peptides as templates. The pioneer was Magainin Pharmaceuticals from Philadelphia (PA USA) in the early 1990s with Pexiganan®, derived from frog skin magainin, but with little success. Another North-American company, Intrabiotics Pharmaceuticals from Mountain View (CA) developed Iseganan®, a synthetic analogue to pig protegrin. Micrologix Biotech from Vancouver (BC Canada) developed several linear antimicrobial peptides, particularly against resistant Staphylococcus aureus. EntoMed from Strasbourg (France) was the first company to use insect (a non revealed tropical butterfly) antimicrobial peptides to fight fungal infections due to Candida and Aspergillus in immunologically compromised patients. Anti Gram+ bacterial activity, particularly Staphylococcus, have also been analyzed. Recently, SelectBiotics from Montpellier (France) has become interested in the peptides produced by several bacterial species to protect themselves from other microorganisms.
KeywordsMinimum Inhibitory Concentration Antimicrobial Peptide Marine Invertebrate White Spot Syndrome Virus Mediterranean Mussel
Unable to display preview. Download preview PDF.
- Bulet, P., Cociancich, S., Dimarq, J-L., Lambert, J., Reichhart, J-M., Hoffmann, D., Hétru, C., and Hoffmann, J.A., 1991, Isolation from a coleopteran insect of a novel inducible antibacterial peptide and of new members of the insect defensin family, J. Biol. Chem. 266:24520–24525.PubMedGoogle Scholar
- Charlet, M., Chernysh, S., Philippe, H., Hétru, C., Hoffmann, J.A., and Bulet, P., 1996, Innate immunity: Isolation of several cysteine-rich antimicrobial peptides from the blodd of a mollusk, Mytilus edulis. J. Biol. Chem. 271:21808–21813.Google Scholar
- Erauso, G., Reysenbach, A.L., Godfroy, A., Meunier, J.R., Crump, B., Partensky, F., Baross, J.A., Marteisson, V., Barbier, G., Pace, N.R., and Prieur, D., 1993, Pyrococcus abyssi sp. nov., a new hyperthermophilic archeon isolated from a deep-sea hydrothermal vent, Arch. Microbiol. 160:338–349.CrossRefGoogle Scholar
- Evans, E.W., Beach, G.G., Wunderlich, J., and Harmon, B.G., 1994, Isolation of antimicrobial peptides from avian heterophils, J. Leuk. Biol. 56:661–667.Google Scholar
- Gaill, F., 1993, Aspects of life development at deep sea hydrothermal vents, FASEB J. 6:558–65.Google Scholar
- Hoffmann, J.A., and Riechhart, J-M., 1997, Drosophila immunity, Tr. Cell Biol. 7:309–316.Google Scholar
- Kohashi, O., Ono, T., Ohki, K., Soejima, T., Moriya, T., Umeda, A., Meno, Y., Amako, K., Funakosi, S., Masuda, M., and Fujii, N., 1992, Bactericidal activities of rat defensins and synthetic rabbit defensins on Staphylococci, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella typhimurium and Escherichia coli, Microbiol. Immunol. 36:369–380.Google Scholar
- Mitta, G., Vandenbulcke, F., Hubert, F., and Roch, Ph., 1999b, Mussel defensins are synthesised and processed in granulocytes then released into plasma after bacterial challenge, J. Cell Sci. 112:4233–4242.Google Scholar
- Mitta, G., Vandenbulcke, F., Noël, T., Romestand, B., Beauvillain, J-C., Salzet, M., and Roch, Ph., 2000c, Differential distribution and defence involvement of antimicrobial peptides in mussel, J. Cell Sci. 113: 2759–2769.Google Scholar
- Osborn, R.W., De Samblanx, G.W., Thevissen, K., Goderis, I., Torrekens, S., Van Leuven, F., Attenborough, S., Rees, S.B., and Broekaert, W.F., 1995, Isolation and characterization of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae, FEBS Letters 368:257–262.PubMedCrossRefGoogle Scholar